Cureatr

Cureatr is a medication management and optimization company that sells tech and tech-enabled services to at-risk health care enterprises.

Funding reportedLast round: Series B

Hospital & Health CareNew York, United States

What company datasets say Cureatr raised

Funding, as reported

Reported in all$34Min dollars

Rounds9

Last roundSeries B

Last round dateApr 2021

Investors listed9

SEC Form D$29M sold, 7 filings, last Aug 2023

From the SEC filings it signed: 4 on the team.

On the board, as filediBharath GanesanJames BradleyJohn ClarkeJoseph MayerPeter Masanotti

Investors who name them

Each firm lists Cureatr on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Cureatr in front of investors. Or tell us what we have wrong.